登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>PCSK9 >EP-103

PCSK9 [Biotinylated] : LDL R Inhibitor Screening ELISA Assay Pair

For research use only.

组分(Materials Provided)

96tests
IDComponentsSize
A006-214Human LDL R35μg
A007-214Biotinylated Human PCSK910μg
A003-214Streptavidin-HRP10μg
PC9-NA003Anti-PCSK9 Neutralizing Antibody40μg

 

480tests
IDComponentsSize
A006-214Human LDL R160μg
A007-214Biotinylated Human PCSK910μg
A003-214Streptavidin-HRP10μg
PC9-NA003Anti-PCSK9 Neutralizing Antibody200μg

背景(Background)

PCSK9 is a crucial protein in the regulation of plasma cholesterol homeostasis. It binds low density lipoprotein receptor (LDL R) to enhance the degradation of LDL R. Therefore, inhibition of PCSK9 has been considered a promising strategy to prevent the receptor from being degraded and promote removal of LDL cholesterol from circulation.

应用说明(Application)

This pair is useful for screening for inhibitors of human PCSK9 binding to human LDL R.

It is for research use only.

重构方法(Reconstitution)

See Certificate of Analysis for details of reconstitution instruction and specific concentration.

存储(Storage)

Upon receipt, please store all items at -70°C.

After reconstitution, the stock solution should be kept at -70°C.

原理(Assay Principles)

This inhibitor screening ELISA pair is designed to facilitate the identification and characterization of new PCSK9 pathway inhibitors. This assay employs a simple colorimetric ELISA platform, which measures the binding between immobilized human LDL R and in-house developed biotinylated PCSK9 protein. This product is uniquely suitable for rapid high-throughput screening of putative PCSK9 inhibitors. Briefly, we provide you with a biotinylated human PCSK9 protein, a human LDL R protein, an anti-PCSK9 neutralizing antibody (as method verified Reference), and Streptavidin-HRP reagent.

Your experiment will include 4 simple steps:

1. Coat the plate with human LDL R.

2. Add your molecule of interest to the plates.

3. Add human PCSK9-Biotin to the plates.

4. Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

Finally, the ability of your compound to inhibit PCSK9: LDL R binding will be determined by comparing OD readings among different experimental groups.

 

典型数据-Typical Data Please refer to DS document for The assay protocol.

PCSK9 TYPICAL DATA

INHIBITION OF PCSK9 [BIOTINYLATED]: LDL R BINDING BY ANTI-PCSK9 NEUTRALIZING ANTIBODY
Serial dilutions of anti-PCSK9 neutralizing antibody (Catalog # PC9-NA003) (1:2 serial dilutions, from 20 μg/mL to 0.04 μg/mL or 133.33 nM to 0.26 nM) were added into Biotinylated PCSK9: LDL R binding reactions. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
PCSK9靶点信息
英文全称:Proprotein convertase subtilisin kexin type 9
中文全称:前蛋白转化酶枯草杆菌蛋白酶Kexin-9
种类:Homo sapiens
上市药物数量:4详情
临床药物数量:26详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定